Profiling the subjective effects of Δ⁹-tetrahydrocannabinol using visual analogue scales.
Daniel Kleinloog, Frits Roozen, Willem De Winter, Jan I Freijer, Joop van Gerven
International Journal of Methods in Psychiatric Research June 2014 DOI: 10.1002/mpr.1424 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pooled analysis of 10 studies Peer reviewed |
|---|---|
| Sample size | 217 |
| Population | Participants in 10 clinical pharmacological studies of THC |
| Intervention | THC |
| Measures | VAS Bond and Lader, VAS Bowdle |
| Topics | Cannabis |
| Keywords | Vas Profile Subjective Visual analogue scales |
| Key points | Across 217 participants from 10 studies, 'feeling high' was the best predictor of THC's subjective effect. The authors report three distinct clusters of subjective effects: perception ('time', 'thoughts', 'high'), relaxation ('drowsy', 'muzzy', 'mentally slow', 'dreamy'), and dysphoria ('voices', 'meaning', 'suspicious'), which they argue may reflect effects on different brain systems. |
Abstract
The subjective effects of cannabis and its main psychoactive component Δ(9) -tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings of relaxation and occasionally dysphoric reactions. These effects are captured by two of the most frequently used visual analogue scales (VASs) in clinical (pharmacologic) research to measure subjective effects: VAS Bond and Lader (alertness, calmness and mood) and VAS Bowdle (psychedelic effects). In this analysis, the effects of THC on these VASs were compared within a total of 217 subjects who participated in 10 different studies. Not surprisingly, the item feeling high was found to be the best predictor for the effect of THC. Three separate clusters that describe the spectrum of subjective effects of THC were identified using different statistical methods, consisting of VAS "time", "thoughts" and "high" ("perception"), VAS "drowsy", "muzzy", "mentally slow" and "dreamy" ("relaxation") and VAS "voices", "meaning" and "suspicious" ("dysphoria"). These results provide experimental evidence that THC can evoke different classes of effects. These distinct subjective clusters could represent effects on various systems in the brain, which can be used to further differentiate the involvement of endocannabinoid systems in health and disease.
Citations in the library
Cited by 9
- Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis Translational Psychiatry September 6, 2022
- The thalamus in psychosis spectrum disorder. Frontiers in Neuroscience 2023
- Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts Journal of Clinical Psychopharmacology August 20, 2021
- Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study Drug and Alcohol Dependence August 11, 2023
- Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition International Clinical Psychopharmacology June 27, 2024
and 4 more in the library
Cites 15
- Psychedelic Effects of Ketamine in Healthy Volunteers Anesthesiology 1998
- Psychosis reactivity to cannabis use in daily life: an experience sampling study The British Journal of Psychiatry May 31, 2010
- Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study The International Journal of Neuropsychopharmacology April 14, 2011
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers Psychological Medicine October 1, 2012
- Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans. British Journal of Clinical Pharmacology July 2013
and 10 more in the library